If you would like to present, start by submitting a proposal. You will need the following: presentation type, short/long descriptions, keywords, focus, themes, and biographical information.
Submit your proposal here.
After we receive your presentation proposal, it moves to the evaluation step. We welcome the submission of proposals at anytime of the year.
All proposals will be reviewed between 24- 48 hr of submission by the Organizing Committee. See proposal deadlines below.
Once your proposal is accepted, you must register before our Program Development team can schedule your presentation.
New vaccine pipeline, Clinical trials of vaccines, Behavioural interventions, Novel Vaccine Delivery Methods, Vaccine Adjuvants, Vaccine Safety, Conjugate Vaccines, Inactivated Vaccines, Live Attenuated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Other Vaccines, Vaccine implementation, Clinical Trials
Enteric vaccines e.g. Cholera, Typhoid and Rotavirus; Mosquito-borne viruses e.g. Dengue, Japanese encephalitis, Zika, Malaria and Chikungunya; Respiratory viruses e.g. Influenza, Respiratory Syncitial virus; Polio; Vaccines Human Papilloma Virus; Measles, Mumps and Rubella (MMR), Hepatitic viruses, others
Cancer Prevention Vaccines- Human papillomavirus (HPV) vaccines, Hepatitis B vaccines, Vaccines for Cancer treatment- Whole tumour vaccines, Antigen vaccines, Dendritic cell vaccines, DNA vaccines , Anti-idiotype vaccines, Autologous cancer vaccines, Allogenic cancer vaccines, Protein or Peptide Cancer Vaccines, DNA Vaccines, Clinical Trials, Monoclonal Antibodies, Biological Response Modifiers, Biological Response Modifiers
General Virology and Their Transmission, Viral Pathogenesis, Host Cell Response To Viral Infection, Diagnosis And Treatment Of Different Viral Infections, Viral Infection, Viral Genome Replication, Viral Oncogenesis, Pathogenesis of virus infections, Mechanisms of Virus Replication, Viral Genetics and Evolution
Basic and translational research, Epidemiology and prevention research, Social and behavioural research, Antiretroviral therapy and strategies for cure, HIV and ageing-related inflammation and immune activation and related drug interactions, Co-infections, Sexually transmitted infections, Treatment as prevention., Novel trial design and monitoring strategies, social and behavioural factors, HIV drug resistance,
Pregnant mothers, Adolescents, Infancy and childhood, Elderly, Paediatric Vaccines, Traveller Vaccines, Therapeutic vaccination, Vaccination in conflict zones and disaster areas, Vaccination of premature infants, Adults with special health conditions, Vaccines for Immigrants and Refugees, Recommended Vaccines for Healthcare Workers;
Viral break out prevention and measures, Diagnostic and early detection of viral infections, Viral Hepatitis, Viral immunology infection & immunity, Antiviral Medicine,Therapeutic approaches & Targets for viral infections, Immunology of virus diseases, Innate immunity, Adaptive immunity
Vaccine safety including unspecific effects of vaccines, Vaccine costs, cost-effectiveness and decision-making, Vaccine registries, Novel consultations, Vaccine Hesitancy, Communications and social mobilization, Vaccination promotion and requirements, The ethics of Vaccine trials; Vaccine injury compensation; Vaccine refusal and the risks of Vaccine-preventable diseases;Vaccine safety monitoring and vaccine pharmacovigilance, Equitable access to vaccines in emergencies
Copyright © IMedical . All rights reserved.